© 2025 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
April Breyer Menon is the founder of April Breyer Menon Consulting. At her business, she maintains a database of information related to biologic patent litigations and inter partes review proceedings and regularly writes presentations and publications related to biosimilar patent law. Breyer Menon obtained her JD degree from Boston College Law School in 2011, prior to which she attended University of Minnesote, where she graduated with a bachelor of Science in Genetics and Cell Biology and a bachelor of Arts in Physiology in 2005.
March 11, 2025
Article
The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and launches anticipated to start in May 2025, while ongoing patent litigation continues to shape the competitive landscape.
July 18, 2022
Article
Two experts in biosimilar intellectual property (IP) law break down the issues that digital health and precision medicine face with IP and the history of case law that has created the current landscape.